ELS-tíðindi - október 2002 - Einkaleyfastofan

10/02
(21) 6560
(22) 20.9.2002
(51) A61K
(54) Lyfjasamsetning fyrir meðhöndlun á
bráðum, þrálátum sársauka og/eða
taugakerfissársauka og mígreni.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Jotham Wadsworth Coe; Edmund
Patrick Harrigan; Brian Thomas O'Neill;
Steven Bradley Sands; Eric Jacob
Watsky; Groton, Connecticut,
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 7.4.2000, US, 60/195,738
(85) 20.9.2002
(86) 16.3.2001, PCT/IB01/00391
(21) 6561
(22) 20.9.2002
(51) C07D
(54) Bensóamíð píperidín efnasambönd
sem P-efnis mótlyf.
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Eric Platt Arnold; Thomas Allen Chappie;
Jianhua Huang; John Michael
Humphrey; Arthur Adam Nagel; Brian
Thomas O'Neill; Susan Beth Sobolov-
Jaynes; Lawrence Albert Vincent;
Groton, Connecticut, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 10.4.2000, US, 60/195,922
20.6.2000, US, 60/212,922
(85) 20.9.2002
(86) 6.4.2001, PCT/IB01/00629
(21) 6562
(22) 23.9.2002
(51) B65D; G01K
(54) Umbúðir, ásamt til þess gerðum
hitamæli, til að geyma til varðveislu
vörur við lækkað hitastig.
(71) Henry Norrby; Mats Nygårdh;
Öjevägen 69, S-820 40 Järvsö; Myra
2289 A, S-820 40 Järvsö, Svíþjóð.
(72) Henry Norrby; Mats Nygårdh; Järvsö,
Svíþjóð.
(74) Kjartan Ragnars, hrl., Hrauntungu
66, 200 Kópavogi.
(30) 27.3.2000, SE, 0001069-4
(85) 23.9.2002
(86) 26.3.2001, PCT/SE01/00650
(21) 6563
(22) 24.9.2002
(51) C07D; A61K; A61P
(54) Hýdroxýfenýl-píperasinýl-metýlbensamíðafleiður
til að meðhöndla
sársauka.
(71) AstraZeneca AB, S-151 85 Södertälje,
Svíþjóð.
(72) William Brown; Niklas Plobeck;
Christopher Walpole; St. Laurent,
Quebec, Kanada.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 4.4.2000, SE, 0001209-6
(85) 24.9.2002
(86) 30.3.2001, PCT/SE01/00709
ELS tíðindi 53
(21) 6564
(22) 24.9.2002
(51) A61M
(54) Nálarlaus sprauta sem verkar með
leifturhleðslu með tvöfaldri samsetningu.
(71) Crossject, 12, Quai Henri IV, 75181
Paris Cedex 04, Frakklandi.
(72) Patrick Alexandre, Gray; Patrick
Cognot, Le Mee Sur Seine; Joël
Lafforgue, Itteville; Denis Roller, La
Ferte Alais; Frakklandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 19.4.2000, FR, 00/05,031
(85) 24.9.2002
(86) 27.3.2001, PCT/FR01/00921
(21) 6565
(22) 24.9.2002
(51) C07D
(54) Trópan afleiður nytsamlegar í meðferð.
(71) Pfizer Inc., 235 East 42nd Street, New
York, New York 10017, Bandaríkjunum.
(72) Manoussos Perros; David Anthony
Price; Blanda Luzia Christa Stammen;
Anthony Wood; Sandwich, Kent,
Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 26.5.2000, GB, 0014046.7
27.6.2000, GB, 0015835.2
(85) 24.9.2002
(86) 9.5.2001, PCT/IB01/00806
(21) 6566
(22) 24.9.2002
(51) C07D; A61K; A61P
(54) Indólín-2-ón afleiður, framleiðsla og
notkun þeirra sem mjaltavaka
(ocytocin) viðtakabindlar.
(71) Sanofi-Synthelabo, 174 Avenue de
France, FR-75013 Paris, Frakklandi.
(72) Loïc Foulon, Portet sur Garonne;
Georges Garcia, Frontignan;
Claudine Serradeil-Le Gal,
Esclaquens; Gérard Valette, Lacroix-
Falgarde; Frakklandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 3.4.2000, FR, 00/04,193
(85) 24.9.2002
(86) 2.4.2001, PCT/FR01/00980
(21) 6567
(22) 24.9.2002
(51) C07D; A61K
(54) Natríum-vetnis skiptilati af gerð 1
(NHE-1).
(71) Pfizer Products Inc., Eastern Point
Road, Groton, Connecticut 06340,
Bandaríkjunum.
(72) Weichao George Chen; Eric David
Cox; Angel Guzman-Perez; Groton,
Connecticut, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 28.4.2000, US, 60/200,432
(85) 24.9.2002
(86) 28.2.2001, PCT/IB01/00277
(21) 6568
(22) 26.9.2002
(51) C01B; H01M
(54) Fjölþrepa brennsla fyrir eldsneytisvinnslu
til að nota með efnarafal.
(71) UOP LLC, 25 Eest Algonquin Road,
Des Plaines, Illinois 60017-5017,
Bandaríkjunum.
(72) John Joseph Senetar; Gavin P.
Towler; John Robert Harness; Des
Plaines, Illinois, Bandaríkjunum.
(74) Sigurjónsson & Thor, ehf.,
Skólavörðustíg 16, 101 Reykjavík.
(30) 29.3.2000, US, 09/538,424
(85) 26.9.2002
(86) 28.3.2001, PCT/US01/10007
(21) 6569
(22) 27.9.2002
(51) C07C; C07D; A61K; A61P
(54) Sýklóhexýlamín afleiða sem valvís
NMDA viðtakamótlyf af undirgerð.
(71) Warner-Lambert Company, 201
Tabor Road, Morris Plains, New
Jersey 07950, Bandaríkjunum.
(72) Russell Joseph Deorazio, Schenectady,
New York; Sham Shridhar Nikam,
Ann Arbor, Michigan; Ian Leslie Scott,
Delanson, New York; Brian Alan
Sherer, Clifton Park, New York;
Lawrence David Wise, Ann Arbor,
Michigan; Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 26.4.2000, US, 60/199,762
(85) 27.9.2002
(86) 24.4.2001, PCT/US01/13176
(21) 6570
(22) 27.9.2002
(51) A61K
(54) Þrýstingslækkandi miðlar og notkun.
(71) Warner-Lambert Company, 201
Tabor Road, Morris Plains, New
Jersey 07950, Bandaríkjunum.
(72) Karen Diane Hitchcock, Pequannock,
New Jersey; Bruce Jeffrey Auerbach,
Ann Arbor, Michigan; Michael John
Ryan, Ann Arbor, Michigan;
Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 20.10.2000, US, 60/242,280
26.4.2000, US, 60/199,855
(85) 27.9.2002
(86) 22.3.2001, PCT/US01/09088
(21) 6571
(22) 27.9.2002
(51) A61K; A61P
(54) Samsett lyfjameðferð.
(71) AnorMed Inc., No. 200-20353, 64th
Avenue, Langley, British Columbia,
Canada V2Y 1N5, Kanada.
(72) Mark Peart Smith; Trevor Charles
Stephens; Macclesfield, Cheshire,
Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 18.5.2000, GB, 0011903.2
(85) 27.9.2002
(86) 10.5.2001, PCT/GB01/02060